Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression
Mehta, Divya, Raison, Charles L., Woolwine, Bobbi J., Haroon, Ebrahim, Binder, Elisabeth B., Miller, Andrew H., Felger, Jennifer C.Volume:
31
Language:
english
Journal:
Brain, Behavior, and Immunity
DOI:
10.1016/j.bbi.2013.04.004
Date:
July, 2013
File:
PDF, 1.54 MB
english, 2013